As PTPN2/N1 inhibition lowered the threshold for TCR signalling and T cell activation (Fig. 2g,h and Extended Data Fig. 1j–n), in addition to enhancing the presentation of tumour antigens, AC484 may affect the repertoire of tumour-reactive T cells. This evidence concerns the gene PTPN2 and neoplasm.